Spebrutinib (LMK-435) is an orally bioavailable, selective inhibitor of Brutons agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity.
Molecular Weight:
423.44
Purity:
97.02%
CAS Number:
[1202757-89-8]
Formula:
C22H22FN5O3
Target:
BTK|||Src
T2603
* VAT and and shipping costs not included. Errors and price changes excepted